Profil
Dr. Hannah Pressler
Charité – Universitätsmedizin Berlin, Deutschland
Präsentation
12:00 CEST / Session: Treatment II: Clinical trials targeting immune dysregulation
Immunoadsorption in ME/CFS and Post-COVID ME/CFS: First Results from the IA-PACS-CFS Randomized Sham-Controlled Trial
